Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intra-arterial Autologous Bone-marrow Mononuclear Cells Infusion for Acute Ischemic Stroke. A Phase II, Open-label, Multicenter, Randomized and Controlled Clinical Trial.

NCT02178657 is registered in ClinicalTrials.gov with Andalusian Initiative for Advanced Therapies as lead sponsor.

NCT NCT02178657
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02178657 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intra-arterial Autologous Bone-marrow Mononuclear Cells Infusion for Acute Ischemic Stroke. A Phase II, Open-label, Multicenter, Randomized and Controlled Clinical Trial.
Lead sponsor
Andalusian Initiative for Advanced Therapies
Phase
Phase 2
Overall status
Completed
Start date
April 30, 2015
Completion date
April 12, 2023
Enrollment
76 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

ischemic stroke